Debt and Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments

A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:

	December 31, 2022				December 31, 2021
	Fair Value		Carrying Value		Fair Value		Carrying Value
3.600% Senior Notes due 2029	$	362,644	$	394,221	$	432,316	$	393,305
3.450% Senior Notes due 2027	280,506		297,775		321,204		297,281
3.700% Senior Notes due 2025	290,874		299,168		318,852		298,798
4.750% Senior Notes due 2025 (DaVinci) (1)	146,625		149,278		166,071		148,969
Total senior notes	1,080,649		1,140,442		1,238,443		1,138,353
Medici Revolving Credit Facility (2)	30,000		30,000		30,000		30,000
Total debt	$	1,110,649	$	1,170,442	$	1,268,443	$	1,168,353

(1)    RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.

(2)        RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s outstanding issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions.

Schedule of Aggregate Amount of Maturities Related to the Company's Debt Obligations

The following table sets forth the scheduled maturity of the Company’s aggregate amount of its debt obligation reflected on its consolidated balance sheet at December 31, 2022:

2023	$	30,000
2024	—
2025	450,000
2026	—
2027	300,000
After 2027	400,000
Unamortized fair value adjustments	—
Unamortized discount and debt issuance expenses	(9,558)
	$	1,170,442

Schedule of Credit Facilities

The outstanding amounts issued or drawn under each of the Company’s significant credit facilities is set forth below:

At December 31, 2022	Issued or Drawn
Revolving Credit Facility (1)	$	—
Medici Revolving Credit Facility (2)	30,000
Bilateral Letter of Credit Facilities
Secured	447,384
Unsecured	625,750
Funds at Lloyd’s Letter of Credit Facility	275,000
	$	1,378,134

(1)At December 31, 2022, no amounts were issued or drawn under this facility.

(2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s outstanding voting rights, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. The drawn amount of the Medici revolving credit facility is included on the Company’s consolidated balance sheets under debt.